| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.33B | 45.55B | 44.74B | 49.34B | 53.95B | 39.11B |
| Gross Profit | 27.03B | 11.65B | 23.88B | 23.30B | 20.20B | 17.06B |
| EBITDA | 20.55B | 16.59B | 14.56B | 13.92B | 12.77B | 11.80B |
| Net Income | 5.04B | 6.29B | 5.61B | 4.80B | 4.34B | 3.88B |
Balance Sheet | ||||||
| Total Assets | 157.57B | 160.76B | 158.29B | 150.03B | 154.67B | 141.75B |
| Cash, Cash Equivalents and Short-Term Investments | 3.34B | 6.35B | 4.57B | 5.47B | 7.47B | 8.40B |
| Total Debt | 56.38B | 59.79B | 57.73B | 61.65B | 50.42B | 44.27B |
| Total Liabilities | 98.15B | 97.34B | 97.24B | 89.74B | 96.55B | 85.63B |
| Stockholders Equity | 53.88B | 50.07B | 47.13B | 43.11B | 41.12B | 40.48B |
Cash Flow | ||||||
| Free Cash Flow | 2.48B | 1.19B | 3.72B | 4.41B | 3.66B | 1.19B |
| Operating Cash Flow | 6.62B | 8.80B | 11.93B | 12.13B | 10.44B | 8.11B |
| Investing Cash Flow | -6.01B | -11.77B | -8.40B | -9.07B | -10.15B | -9.49B |
| Financing Cash Flow | -2.21B | 2.80B | -2.27B | -2.35B | 151.00M | 1.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | €23.86B | 12.42 | 22.84% | 6.66% | 2.66% | 1.26% | |
67 Neutral | €3.84B | 179.64 | 3.85% | 7.01% | 5.35% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | €35.24B | 14.75 | 26.20% | 4.32% | -2.54% | 103.14% | |
62 Neutral | €129.35B | 31.54 | 11.50% | 2.92% | 0.50% | -19.06% | |
62 Neutral | €7.99B | 16.24 | 10.14% | 4.27% | -23.15% | -39.13% | |
52 Neutral | €6.45B | 11.10 | 13.06% | 2.02% | 2.05% | 307.60% |